Innova Captab Limited reported healthy results for Q3 FY25, with Revenue from Operations at ₹ 316.5 crores and Profit After Tax (PAT) at ₹ 34.2 crores

 

Mumbai : Innova Captab Limited (BSE: 544067, NSE: INNOVACAP) is a leading integrated pharmaceutical company committed to delivering high-quality healthcare solutions through a robust presence across the entire pharmaceuticals value chain, including research and development, manufacturing, distribution, marketing, and exports. The company is pleased to announce its financial results for the quarter and nine months ending December 31st, 2024.

• Revenue from Operations was ₹ 316.5 crores in the quarter vs ₹ 302.5 crores last year, registering growth of 4.6%
• EBITDA grew to ₹ 50.9 crores vs ₹ 46.9 crores last year. EBITDA Margins also improved to 16.1% vs 15.5% in Q3 FY24
• Profit after Tax improved significantly to ₹ 34.2 crores vs ₹ 25.1 crores (YoY growth of 36.3%). PAT Margins improved to 10.8% from 8.3%

 

• Revenue from Operations grew 13.5% to ₹ 928.9 crores vs ₹ 818.7 crores during same period in the previous year
• EBITDA increased to ₹ 147.1 crores vs ₹ 123.2 crores (YoY improvement of 19.4%). EBITDA margins improved by 80 bps to 15.8%
• Profit after Tax grew by 50.5% to ₹ 98.7 crores vs ₹ 65.6 crores in 9M FY24. PAT Margin increased to 10.6% from 8.0%

Commenting on the results, Mr. Vinay Lohariwala, Managing Director – Innova Captab Limited said We are delighted to report a healthy performance in Q3 and 9M FY25, driven by robust resilience in our core business operations and strategic advancements. Our revenue from operations registered YoY growth of 4.6% in Q3 FY25 and of 13.5% in 9M FY25. PAT demonstrated strong surge of 36.3% in Q3 FY25 and of 50.5% in 9M FY25.

Key highlight of the quarter was the successful launch of operations at our new Kathua, Jammu facility, where we commenced commercial production on January 14, 2025. This milestone represents a pivotal moment in our growth trajectory, bolstering both our production capacity and our ability to meet the evolving demands of our customers. This expansion is a cornerstone of our long-term strategic vision, reinforcing our market position and laying the foundation for sustained, profitable growth. With the added advantage of incentives from the central government, we are optimistic about the positive impact on profitability from the Jammu operations.

As we look to the future, we are confident in the continued strength and resilience of our business. With a diversified portfolio and a steadfast commitment to long-term value creation, our teams are united in executing our strategic priorities. We are well-positioned for sustained growth and are excited to build on this momentum in the years ahead.

(amount in ₹ crores except otherwise mentioned)

Particulars	Q3 FY25	Q3 FY24	YoY Growth
Revenue from Operations	316.5	302.5	4.6%
EBITDA	50.9	46.9	8.5%
EBITDA Margin (%)	16.1%	15.5%	60 bps
Profit before Tax	45.6	35.2	29.5%
Profit after Tax	34.2	25.1	36.3%

Particulars	9M FY25	9M FY24	YoY Growth
Revenue from Operations	928.9	818.7	13.5%
EBITDA	147.1	123.2	19.4%
EBITDA Margin (%)	15.8%	15.0%	80 bps
Profit before Tax	131.7	90.0	46.3%
Profit after Tax	98.7	65.6	50.5%